Clinical and experimental study on human neuronal circuitry and cellular heterogeneity impacted by early Alzheimer's disease -related pathology in iNPH patients (CLEAR)
Acronym
CLEAR
Description of the granted funding
This study aims to elucidate the cellular heterogenicity and neuronal network functions impacted by the early AD pathology in humans. We take advantage of the brain biopsies obtained during shunt surgeries of idiopathic normal pressure hydrocephalus patients from which a subpopulation of patients show early AD pathology including beta-amyloid deposits and tau as well as their extensive clinical history. We combine single cell sequencing with spatial mapping and electrophysiological recordings to reveal how early AD pathology promotes cellular dysfunctions in humans. This will pinpoint novel molecular targets for further validation and possibly new biomarkers.
Show moreStarting year
2021
End year
2025
Granted funding
Role in consortium of the Academy of Finland
Leader
Other consortium parties
Other information
Funding decision number
339763
Fields of science
Neurosciences
Research fields
Neurotiede
Identified topics
brain, neuroscience